IMUX 10-Q: SEC filing

Immunic, Inc.

Filed with the SEC on · accession 0001280776-26-000021

IMUX filed a 10-Q (quarterly report) with the SEC on Nov 13, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -1.1% by the first close after the filing.

Summary of the filing

Immunic, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing details of recent private placement financings involving common stock, pre-funded warrants, and Series B warrants.

Key details

FilerImmunic, Inc.

How IMUX stock reacted

Close before

$7.79

Nov 12, 2026

First close after

-1.09%

$7.71

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for IMUX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for IMUX?

Click here

Frequently asked questions

What did IMUX file with the SEC on Nov 13, 2026?

IMUX filed a 10-Q (SEC filing). Immunic, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing details of recent private placement financings involving common stock, pre-funded warrants, and Series B warrants.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did IMUX stock react to this filing?

IMUX closed at $7.79 before the filing and $7.71 on Nov 13, 2026 (-1.09%).

Other IMUX SEC filings

Get alerts when IMUX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days